home / stock / rcel / rcel quote
Last: | $ |
---|---|
Change Percent: | -2.16% |
Open: | $10.72 |
Close: | $10.44 |
High: | $10.8249 |
Low: | $10.15 |
Volume: | 705,544 |
Last Trade Date Time: | 02/12/2020 04:43:59 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $10.72 | $10.44 | $10.8249 | $10.15 | 705,544 | 02-12-2020 |
$ | $10.62 | $10.67 | $10.70 | $10.535 | 451,887 | 02-11-2020 |
$ | $10.00 | $10.29 | $10.38 | $9.95 | 563,641 | 02-10-2020 |
$ | $9.74 | $9.58 | $9.74 | $9.47 | 280,570 | 02-07-2020 |
$ | $9.86 | $9.80 | $9.89 | $9.61 | 356,077 | 02-06-2020 |
$ | $9.83 | $9.76 | $9.87 | $9.66 | 416,564 | 02-05-2020 |
$ | $9.35 | $9.59 | $9.65 | $9.35 | 469,515 | 02-04-2020 |
$ | $9.13 | $9.13 | $9.17 | $8.655 | 691,072 | 02-03-2020 |
$ | $9.00 | $8.55 | $9.07 | $8.51 | 555,900 | 01-31-2020 |
$ | $8.90 | $8.73 | $8.90 | $8.52 | 705,163 | 01-30-2020 |
$ | $9.10 | $9.29 | $9.3896 | $9.10 | 351,466 | 01-29-2020 |
$ | $8.89 | $8.86 | $8.952 | $8.80 | 279,177 | 01-28-2020 |
$ | $9.00 | $8.96 | $9.2399 | $8.78 | 557,083 | 01-27-2020 |
$ | $9.48 | $9.39 | $9.50 | $9.00 | 612,795 | 01-24-2020 |
$ | $9.40 | $9.57 | $9.59 | $9.40 | 353,305 | 01-23-2020 |
$ | $9.92 | $9.48 | $9.98 | $9.42 | 777,359 | 01-22-2020 |
$ | $10.21 | $9.95 | $10.2649 | $9.91 | 370,231 | 01-21-2020 |
$ | $10.45 | $10.22 | $10.54 | $10.10 | 392,168 | 01-20-2020 |
$ | $10.45 | $10.22 | $10.54 | $10.10 | 391,749 | 01-17-2020 |
$ | $10.45 | $10.38 | $10.47 | $10.21 | 356,546 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Avita Medical Inc. Company Name:
RCEL Stock Symbol:
NYSE Market:
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) (the "Company"), a regenerative medicine compan...
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial re...
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...